BioScrip Inc. (BIOS) Drops 6.7% on February 01

Equities Staff |

BioScrip Inc. (BIOS) was one of the Russell 2000's biggest losers for Monday February 01 as the stock slid 6.7% to $1.67, a loss of $-0.12 per share. Starting at an opening price of $1.77 a share, the stock traded between $1.63 and $1.80 over the course of the trading day. Volume was 413,124 shares over 1,910 trades, against an average daily volume of 1.04 million shares and a total float of 68.75 million.

The losses send BioScrip Inc. down to a market cap of $114.81 million. In the last year, BioScrip Inc. has traded between $6.33 and $1.19, and its 50-day SMA is currently $1.77 and 200-day SMA is $2.68.

BioScrip Inc provides home infusion & other home healthcare services to patients, physicians, hospitals, healthcare payors & pharmaceutical manufacturers to provide clinical management solutions & delivers cost-effective access to medications.

BioScrip Inc. is based out of Elmsford, NY and has some 2,490 employees. Its CEO is Richard M. Smith.

For a complete fundamental analysis analysis of BioScrip Inc., check out Equities.com’s Stock Valuation Analysis report for BIOS. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

H-Source Holdings Ltd.

H-Source Holdings Inc. is a technology company operating within the healthcare industry through its subsidiary, H-Source, Inc. The Company has developed a transaction platform that provides a private, secure and…

Private Markets

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…

Snapchat

Snapchat is the fastest way to share a moment with friends. The mobile app, allows users to not only share photos with friends but also control how long they can…